Literature DB >> 2234391

(D, L) polylactide microspheres as embolic agent. A preliminary study.

P Flandroy1, C Grandfils, J Collignon, A Thibaut, N Nihant, S Barbette, R Jerome, P Teyssie.   

Abstract

Owing to their shape, accurately calibrated microspheres appear to be very suitable material for distal embolization. Moreover, the biocompatible (D, L) polyactide (PLA) microspheres possess two other valuable advantages: easy adjustment of their biodegradation rate, and incorporation of chemotherapeutic agents during their production. The authors describe the preparation of these (D, L) PLA microspheres and their clinical applications as a preliminary step to arterial chemoembolization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2234391     DOI: 10.1007/bf00593051

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  9 in total

1.  Mortalities associated with use of a commercial suspension of polyvinyl alcohol.

Authors:  I Repa; G P Moradian; L P Dehner; S M Tadavarthy; D W Hunter; W R Castañeda-Zúñiga; G B Wright; H Katkov; P Johnson; B Chrenka
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

2.  Dextran microsphere embolization: experimental and clinical experience with radiologic-pathologic correlation. Work in progress.

Authors:  J E Dion; R N Rankin; F Viñuela; A J Fox; A C Wallace; M Mervart
Journal:  Radiology       Date:  1986-09       Impact factor: 11.105

3.  Chemoembolization: principles and perspectives.

Authors:  P Madoule; P Trampont; A Roche
Journal:  J Microencapsul       Date:  1984 Jan-Mar       Impact factor: 3.142

4.  Improved regional selectivity of hepatic arterial BCNU with degradable microspheres.

Authors:  S Dakhil; W Ensminger; K Cho; J Niederhuber; K Doan; R Wheeler
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

5.  Partial splenic embolization using polyvinyl alcohol foam, dextran, polystyrene, or silicone. An experimental study in dogs.

Authors:  K C Wright; J H Anderson; C Gianturco; S Wallace; V P Chuang
Journal:  Radiology       Date:  1982-02       Impact factor: 11.105

6.  Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat.

Authors:  N Willmott; J Cummings; J F Stuart; A T Florence
Journal:  Biopharm Drug Dispos       Date:  1985 Jan-Mar       Impact factor: 1.627

7.  Sustained-release properties of microencapsulated mitomycin C with ethylcellulose infused into the renal artery of the dog.

Authors:  T Kato; R Nemoto; H Mori; I Kumagai
Journal:  Cancer       Date:  1980-07-01       Impact factor: 6.860

8.  Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil.

Authors:  S Fujimoto; M Miyazaki; F Endoh; O Takahashi; K Okui; Y Morimoto
Journal:  Cancer       Date:  1985-11-15       Impact factor: 6.860

9.  Arterial chemoembolization with cisplatin microcapsules.

Authors:  Y Okamoto; A Konno; K Togawa; T Kato; Y Tamakawa; Y Amano
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

  9 in total
  6 in total

1.  The utility of the microcrystalline cellulose sphere as a particulate embolic agent: an experimental study.

Authors:  Y Kai; J Hamada; M Morioka; T Todaka; S Hasegawa; Y Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Clinical evaluation of cellulose porous beads for the therapeutic embolization of meningiomas.

Authors:  Y Kai; J-I Hamada; M Morioka; S Yano; H Nakamura; K Makino; T Mizuno; H Takeshima; J-I Kuratsu
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

3.  Preoperative cellulose porous beads for therapeutic embolization of meningioma: provocation test and technical considerations.

Authors:  Yutaka Kai; Jun-Ichiro Hamada; Motohiro Morioka; Shigetoshi Yano; Hideo Nakamura; Keishi Makino; Takamasa Mizuno; Hideo Takeshima; Jun-Ichi Kuratsu
Journal:  Neuroradiology       Date:  2007-02-22       Impact factor: 2.804

4.  Microparticles prepared from sulfenamide-based polymers.

Authors:  Sheetal R D'Mello; Jun Yoo; Ned B Bowden; Aliasger K Salem
Journal:  J Microencapsul       Date:  2013-07-18       Impact factor: 3.142

5.  Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability.

Authors:  N Nihant; C Schugens; C Grandfils; R Jérôme; P Teyssié
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

6.  Histopathological evaluation of polymethyl methacrylate as an embolic agent.

Authors:  V V Radhakrishnan; A Saraswathy; V R Rao; D Rout; A Jayakrishnan
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.